Cyclooxygenase blockade elevates leukotriene E4 production during acute anaphylaxis in sheep

Area of Science:

• Immunology
• Pharmacology
• Biochemistry

Background:

• Anaphylaxis involves complex mediator release.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) can cause adverse reactions.

Purpose of the Study:

• To investigate eicosanoid changes during acute anaphylaxis in sheep.
• To explore the role of NSAIDs in modulating these changes and their potential clinical implications.

Main Methods:

• Radioimmunoassay (RIA) for measuring thromboxane B2 and 6-ketoprostaglandin F1 alpha.
• High-performance liquid chromatography (HPLC) for identifying sulfidopeptide leukotrienes (SPLT).
• Experimental model using sensitized and nonsensitized sheep with and without indomethacin treatment.

Main Results:

• Anaphylaxis induced rapid, significant increases in thromboxane B2 and 6-ketoprostaglandin F1 alpha.
• Indomethacin treatment blocked cyclooxygenase products but led to a marked increase in sulfidopeptide leukotrienes (LTE4) during anaphylaxis.
• No significant SPLT changes were observed in untreated animals during anaphylaxis.

Conclusions:

• NSAIDs may exacerbate anaphylactic reactions by shunting metabolism towards increased sulfidopeptide leukotriene synthesis.
• Elevated LTE4 may contribute to adverse NSAID effects, including cardiopulmonary and renal issues.
• Increased leukotriene production might limit the anti-inflammatory efficacy of NSAIDs.